Partnered Programs
Oncology (Immuno-oncology focus)
Clinical (Phase unspecified)Active
Key Facts
Indication
Oncology (Immuno-oncology focus)
Phase
Clinical (Phase unspecified)
Status
Active
Company
About Lynx Biosciences
Lynx Biosciences is a San Diego-based biotech company pioneering a data-first, multi-omic platform for drug discovery in immuno-oncology. The company combines patient-derived ex vivo models, high-content imaging, and deep learning to generate systems-level biological insights, which it applies through strategic partnerships with biopharma companies and an internal therapeutic pipeline. Founded in 2019 and incubated at J&J JLABS, LynxBio is led by an experienced team and has appointed a Chief Business Officer with a strong track record in oncology partnering to drive its commercial strategy and growth.
View full company profileTherapeutic Areas
Other Oncology (Immuno-oncology focus) Drugs
| Drug | Company | Phase |
|---|---|---|
| Internal Pipeline (undisclosed) | Lynx Biosciences | Pre-clinical/Discovery |